Cite
MLA Citation
LC Coates et al.. “SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 948–949. http://access.bl.uk/ark:/81055/vdc_100135161631.0x000061